This announcement is a separate document:
北京市康达律师事务所关于北京昭衍新药研究中心股份有限公司注销2020年股权激励计划第三个行权期已到期未行权股票期权的法律意见书
Legal Opinion of Beijing Kangda Law Firm on Beijing Zhaoyan New Pharmaceutical Research Center Co., Ltd. cancelling unexercised stock options that have expired during the third exercise period of the 2020 Equity Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated